MedDataX Logo

GENSARC 2008 : Medical Economic Evaluation of the Molecular Detection by FISH (Fluorescent in Situ Hybridization) and by PCR (Polymerase Chain Reaction) of Sarcomas Specific Translocations and Amplifications .

NCT ID: NCT00847691

Last Updated: 2012-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical and histological diagnosis of sarcomas is often very difficult. The identification of chromosomal and molecular anomalies, such as amplifications, deletions or fusion genes is a powerful help for establishing a correct diagnosis of sarcomas and their benign counterparts. However, the cost of the cytogenetic and molecular techniques for the detection of these alterations is often a limitation to their use. The aim of our study is to evaluate the direct cost of the molecular techniques in comparison to the cost that would be generated by an appropriate therapy and care management of the patient in case of an erroneous diagnosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

economic evaluation diagnostics sarcoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sarcoma

patients with biopsy or excision of sarcoma (suspected or diagnosed)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with biopsy or excision of sarcoma (suspected or diagnosed)
* sampling reviewed by pathologists
* frozen sampling
* clinical data available

Exclusion Criteria

* opposition of patient
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute, France

OTHER_GOV

Sponsor Role collaborator

Centre Hospitalier Universitaire de Nice

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Florence PEDEUTOUR, PhD

Role: PRINCIPAL_INVESTIGATOR

Laboratoire de Génétique des Tumeurs Solides

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Departement de Pathologie de l'Institut Bergonié

Bordeaux, , France

Site Status

Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Lille

Lille, , France

Site Status

Département d'Anantomie et de Cytologie Pathologie, Centre Léon Berard

Lyon, , France

Site Status

Laboratoire de Génétique des Tumeurs Solides

Nice, , France

Site Status

Institut Curie

Paris, , France

Site Status

Service d'Anatomo-Pathologie, Centre Paul Strauss

Strasbourg, , France

Site Status

Unité de Biologie Moléculaire, CHU de Hautepierre

Strasbourg, , France

Site Status

Département de biologie et de pathologie médicales, Institut Gustave roussy

Villejuif, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PSTIC GENSARC

Identifier Type: -

Identifier Source: org_study_id